|
TATDN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.858300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.384250E-02 |
| Normal-vs-Stage2 |
4.903900E-02 |
| Normal-vs-Stage3 |
4.755400E-01 |
| Normal-vs-Stage4 |
4.466100E-02 |
| Stage1-vs-Stage2 |
8.076800E-01 |
| Stage1-vs-Stage3 |
3.155600E-01 |
| Stage1-vs-Stage4 |
9.793800E-02 |
| Stage2-vs-Stage3 |
2.926800E-01 |
| Stage2-vs-Stage4 |
2.023000E-01 |
| Stage3-vs-Stage4 |
3.839700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.936500E-03 |
| Normal-vs-AfricanAmerican |
1.740410E-02 |
| Normal-vs-Asian |
8.412400E-01 |
| Caucasian-vs-AfricanAmerican |
8.742600E-01 |
| Caucasian-vs-Asian |
5.955600E-01 |
| AfricanAmerican-vs-Asian |
5.179800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.628500E-02 |
| Normal-vs-Female |
5.101600E-03 |
| Male-vs-Female |
2.906000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.281800E-02 |
| Normal-vs-Extreme_Weight |
1.184030E-02 |
| Normal-vs-Obese |
7.172000E-02 |
| Normal-vs-Extreme_Obese |
8.613400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.766000E-01 |
| Normal_Weight-vs-Obese |
4.326800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.914970E-01 |
| Extreme_Weight-vs-Obese |
3.857200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.826550E-01 |
| Obese-vs-Extreme_Obese |
2.459200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.916000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.620500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.106500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.569830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.073200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.552370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.194800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.872800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.267200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.852000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.424600E-03 |
| Normal-VS-Type2 PRCC |
1.495970E-01 |
| Normal-VS-KIRP CIMP |
6.724100E-02 |
| Normal-VS-Unclassified PRCC |
6.018800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.182200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.691200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.408610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.270600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.495400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.416970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.999200E-01 |
| Normal-vs-N1 |
3.142400E-02 |
| Normal-vs-N2 |
5.158800E-01 |
| N0-vs-N1 |
1.816480E-02 |
| N0-vs-N2 |
6.469600E-01 |
| N1-vs-N2 |
5.315600E-01 |
|
|
